BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Genedata Releases New Request Management System for Biotherapeutics R&D Processes

  Request and task management software increases operational efficiency of biopharma R&D organizations

  February 12, 2019

   · 

  3 min read
• 

  Adocia to Present New Clinical Data on BioChaperone® Technology at the 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019)

  Adocia announced that four abstracts featuring its BioChaperone® technology have been accepted for presentation at the 12th International Conference on Advanced Technologies & Treatments for Diabetes being held February 20-23, 2019 in Berlin, Germany.

  February 12, 2019

   · 

  5 min read
• 

  Business

  Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2018 Financial Results and Corporate Update

  Ultragenyx Pharmaceutical Inc. announced that it will host a conference call on Tuesday, February 19, 2019 at 5pm ET to discuss its financial results and corporate update for the fourth quarter and the year ended December 31, 2018.

  February 12, 2019

   · 

  1 min read
• Pharm Country

  Zack’s Investment Research, Inc. Research Report Update on Soligenix

  Analyst David Bautz, PhD of Zack’s Investment Research, Inc. updated coverage on Soligenix, Inc. on February 12, 2019. For more information, please visit SCR.Zacks.com.

  February 12, 2019

   · 

  1 min read
• Business

  Medigene AG: Medigene appoints Axel-Sven Malkomes as CFO/CBDO

  Medigene AG announced that its Supervisory Board has appointed Axel-Sven Malkomes as Chief Financial Officer and Chief Business Development Officer effective 1 April 2019.

  February 12, 2019

   · 

  3 min read
• Policy

  Soligenix Receives US Patent Expanding Protection for its Ricin Toxin Vaccine, RiVax®

  Soligenix, Inc. announced the allowance of a new United States patent protecting its ricin toxin vaccine, RiVax®.

  February 12, 2019

   · 

  9 min read
• Drug Development

  New therapeutic target found for aggressive pediatric cancers with few treatment options

  Preclinical study identifies vulnerability in orphan cancers with SMARCB1 mutations, spurs launch of Phase II clinical trial

  February 12, 2019

   · 

  4 min read
• 

  Drug Development

  ASCO GU Preview: Merck, Bristol-Myers Squibb, Pfizer and More

  The American Society of Clinical Oncology 2019 Genitourinary Cancers Symposium (ASCO GU) is being held in San Francisco from February 14-16. Ahead of the conference, several companies have announced presentations. Here’s a look at just a few.

  February 12, 2019

   · 

  4 min read

   · 

  Mark Terry
• 

  Policy

  J&J’s Esketamine Clears Advisory Panel Hurdle for Depression Treatment

  On Tuesday, a U.S. Food and Drug Administration advisory panel overwhelmingly supported approval of the nasal spray treatment.

  February 12, 2019

   · 

  2 min read

   · 

  Alex Keown
• Business

  Recipharm appoints new Director of Business Management

  Recipharm, the contract development and manufacturing organisation, has appointed a new director of business management for the USA and Canada to accelerate growth in the region.

  February 12, 2019

   · 

  2 min read